Therapy Areas: Allergy
16 July 2018 - - Waltham, Massachusetts-based life sciences company Thermo Fisher Scientific's advanced diagnostic allergic sensitization tests will be offered by Heal, a physician house call ser...
11 July 2018 - Lupus research company the Lupus Foundation of America said on Tuesday that it plans to co-fund a major phase II study to evaluate mesenchymal stem cells (MSC) in the treatment of moder...
10 July 2018 - - Cambridge, Massachusetts-based serious and rare disease therapeutics developer Acceleron Pharma Inc. (NASDAQ: XLRN) has appointed Robert K. Zeldin, M.D. as chief medical officer (CMO)...
6 July 2018 - Acceleron Pharma Inc (Nasdaq:XLRN), a biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, announced on Thursday that i...
6 July 2018 - Singapore-based ASLAN Pharmaceuticals has submitted a clinical trial authorisation application to start a phase one trial of ASLAN004 with the Singapore Health Sciences Authority, it was...
6 July 2018 - Biopharmaceutical company Acceleron Pharma Inc (NASDAQ:XLRN) revealed on Thursday the appointment of Robert K. Zeldin, MD as its chief medical officer. (CMO).In the medical department, D...